Home » Topics » BioWorld Science

BioWorld Science
RSS

Neurotrope initiates enrollment in confirmatory phase II study of bryostatin-1

July 17, 2018

Promising data presented from completed pivotal study of PRO-140 with HAART for HIV-1

July 17, 2018

Concentric Analgesics initiates phase II trial of CA-008 to treat postsurgical pain

July 17, 2018

Rimeporide well tolerated in boys with Duchenne muscular dystrophy

July 17, 2018

Longitudinal study confirms fat, disputes sugar as obesity cause in mice

July 17, 2018

Animal model of HAAF provides insight on pathological process of the disease

July 17, 2018

Novel mouse model of miR-7-induced pancreatic beta-cell dedifferentiation

July 17, 2018

A mosaic HIV-1 vaccine is assessed in a phase I/IIa trial and in rhesus monkeys

July 17, 2018

A designer supramolecule AK-750 amplifies innate immune responses in preclinical models of cancer

July 17, 2018

Specific redox enzyme helps reverse fibrosis

July 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026